0001104659-20-083455.txt : 20200714
0001104659-20-083455.hdr.sgml : 20200714
20200714164623
ACCESSION NUMBER: 0001104659-20-083455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200710
FILED AS OF DATE: 20200714
DATE AS OF CHANGE: 20200714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Apple Tree Partners IV, L.P.
CENTRAL INDEX KEY: 0001593440
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 201027496
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-468-5800
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10169
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ATP III GP, Ltd.
CENTRAL INDEX KEY: 0001593453
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 201027497
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-468-5800
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
a4.xml
4
X0306
4
2020-07-10
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001593440
Apple Tree Partners IV, L.P.
C/O AKERO THERAPEUTICS, INC.,
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
0
0
1
0
0001593453
ATP III GP, Ltd.
C/O AKERO THERAPEUTICS, INC.,
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
0
0
1
0
Common Stock
2020-07-10
4
P
0
415000
36
A
5830203
D
On July 10, 2020, Apple Tree Partners, IV, L.P. ("ATP") purchased 415,000 shares of common stock of the Issuer at a price of $36.00 per share pursuant to an underwritten public offering.
These shares are owned directly by ATP. ATP III GP, Ltd. ("ATP GP") is the sole general partner of ATP. Seth L. Harrison is a director on the Issuer's board of directors and is the sole director of ATP GP. ATP GP disclaims beneficial ownership of the shares listed, except to the extent of its pecuniary interest therein.
/s/ Jonathan Young, as attorney-in-fact
2020-07-14